Keywords: results, taiwanese, zadaxin, study, sciclone, pharmaceuticals, presented

Results From Taiwanese Zadaxin Study

Article | 18 March 1996

Print This

SciClone Pharmaceuticals has presented data from one of its Phase III studies of Zadaxin (thymosin alpha 1), a candidate treatment for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in